Jennifer L. Davis - 03 Dec 2025 Form 4 Insider Report for PROCTER & GAMBLE Co (PG)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Dec 2025, 10:22:27 UTC
Prior SEC filing
06 Oct 2025
Next SEC filing
12 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Wednesday Shipp, attorney-in-fact for Jennifer L. Davis

Key filing fact

Jennifer L. Davis filed Form 4 for PROCTER & GAMBLE Co (PG) on 05 Dec 2025.

Key facts

  • This page summarizes Jennifer L. Davis's Form 4 filing for PROCTER & GAMBLE Co (PG).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 05 Dec 2025, 10:22.

Change

  • Previous filing in this sequence was filed on 06 Oct 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001916665 Primary reporting owner

Davis Jennifer L.

Relationship
CEO - Health Care
Address
1 PROCTER & GAMBLE PLAZA, CINCINNATI
Signature
/s/ Wednesday Shipp, attorney-in-fact for Jennifer L. Davis
Signature date
05 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PG transaction

Common Stock

Options Exercise

Transaction value
$8,723
Shares
+60
Change %
+0.1%
Price
$144.35
Shares after
61,829
Date
03 Dec 2025
Ownership
Direct
Footnotes
F1
PG transaction

Common Stock

Tax liability

Transaction value
$8,723
Shares
-60
Change %
-0.1%
Price
$144.35
Shares after
61,768
Date
03 Dec 2025
Ownership
Direct
Footnotes
F2
PG holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
15,535
Date
03 Dec 2025
Ownership
By Retirement Plan Trustee

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PG transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+34
Change %
+15%
Price
$0.000000
Shares after
263
Date
17 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
34
Exercise price
Footnotes
F3, F4
PG transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-60
Change %
-5.9%
Price
$0.000000
Shares after
966
Date
03 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
60
Exercise price
Footnotes
F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.

Footnote F2

Shares withheld to cover taxes on previous Restricted Stock Unit grant.

Footnote F3

Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.

Footnote F4

These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.

Footnote F5

Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .